by | PRNewswire Asia
Integrates ToolGen’s best-in-class CRISPR-Cas9 platform with GenEditBio’s industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea,...
by | PRNewswire Asia
Engineered by Australia’s leading probiotics expert, this high CFU probiotic delivers the ultimate gut defense, helping to reduce gut transit time by up to 18 hours. SINGAPORE, Nov. 24, 2025 /PRNewswire/ — Life-Space, Australia’s...
by | PRNewswire Asia
Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying conditions – against respiratory syncytial virus (RSV), with proven high and sustained efficacy, a favourable safety...
by | PRNewswire Asia
Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ — Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on...
by | PRNewswire Asia
KARIMUN, Riau Islands, Indonesia, Nov. 24, 2025 /PRNewswire/ — Aslan Energy Capital (Aslan), headquartered in Singapore, today announced the signing of a Heads of Agreement with the Government of Karimun Regency, Riau Islands, Indonesia — strategically located...
by | PRNewswire Asia
More than half of Hongkongers (54%) rank physical health as their top well-being priority, compared to around one in three globally (35%) Weight management emerges as a key health focus, with 43% of Hongkongers prioritizing weight maintenance, well above the global...
